Roy Baynes Senior Vice President - Oncology Therapeutics, Ph.D
Kevin Young Executive Vice President - Commercial Operations
Gilead Diversification Suggestion
Use Gilead to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Gilead to be traded at $67.92 in 30 days
Gilead Price and Market Media
The median price of Gilead for the period between Mon, Nov 11, 2013 and Wed, Dec 11, 2013 is 72.42 with a coefficient of variation of 3.68. The daily time series for the period is distributed with a sample standard deviation of 2.63, arithmetic mean of 71.6, and mean deviation of 2.29. The Stock received substential amount of media coverage during this period.
Gilead Sciences Inc [GILD] is traded on NASDAQ in USA. It is located in Foster City, CA and employs 5,000 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 111.05 B. Gilead Sciences Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 1.53 B outstanding shares of which 60.04 M shares are currently shorted by private and institutional investors with about 7.4 trading days to cover.
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory